Loading stock…

The Campbell's Company (CPB) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

CPBThe Campbell's

Revenue FY25$10.3B

GROWTH RATING↗

——

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+1%3

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR-1%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27Ena–

EPS growth, FY28E+8%6

EPS growth, FY29E+5%5

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 5%/yr vs revenue -1%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 100% of companies worldwide.

Revenue grew 1%/yr over the last 3 years, behind 70% of companies worldwide.3/10

Revenue is set to shrink 1%/yr over the next 3 years, behind most of the market.2/10

Revenue grew 1%/yr over the last 3 years and is set to slip around 1%/yr from here.

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business edging into decline. The one thing to watch: the 3-year revenue record is weak.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-16%2

YTD return-27%2

MID & LONG-TERM▾SCORE

% of 52-week high63%2

1-year return-35%1

3-year return-45%1

5-year return-45%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-45% over three years and -45% over five), behind 80% of the market.

It's down 35% over the past year, now 37% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-16%) and so far this year (-27%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Campbell's. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CPBThe Campbell's

Revenue FY25$10.3B

GROWTH RATING↗

——

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+1%3

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR-1%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27Ena–

EPS growth, FY28E+8%6

EPS growth, FY29E+5%5

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 5%/yr vs revenue -1%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 100% of companies worldwide.

Revenue grew 1%/yr over the last 3 years, behind 70% of companies worldwide.3/10

Revenue is set to shrink 1%/yr over the next 3 years, behind most of the market.2/10

Revenue grew 1%/yr over the last 3 years and is set to slip around 1%/yr from here.

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business edging into decline. The one thing to watch: the 3-year revenue record is weak.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-16%2

YTD return-27%2

MID & LONG-TERM▾SCORE

% of 52-week high63%2

1-year return-35%1

3-year return-45%1

5-year return-45%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-45% over three years and -45% over five), behind 80% of the market.

It's down 35% over the past year, now 37% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-16%) and so far this year (-27%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Campbell's. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

The Campbell's Company

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Campbell's. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Campbell's. Get the full investment case.

Premium